Dopamine in the striatum modulates seizures in a genetic model of absence epilepsy in the rat

Neuroscience

Volumn 100, Issue 2, 2000, Pages 335-344

  Deransart, C ^a   Riban, V ^b   Le B T ^b   Marescaux, C ^b   Depaulis, A ^b  

^a UNIVERSITY OF FREIBURG   (Germany)

^b INSERM   (France)

Author keywords

Basal ganglia; Dopamine; Epilepsy; Genetic model; Nucleus accumbens; Substantia nigra pars reticulata

Indexed keywords

2 AMINO 4 METHYL 5 PHOSPHONO 3 PENTENOIC ACID; 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; 4 AMINOBUTYRIC ACID A RECEPTOR STIMULATING AGENT; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; APOMORPHINE; BROMOCRIPTINE; DOPAMINE 1 RECEPTOR; DOPAMINE 1 RECEPTOR BLOCKING AGENT; DOPAMINE 1 RECEPTOR STIMULATING AGENT; DOPAMINE 2 RECEPTOR; DOPAMINE 2 RECEPTOR BLOCKING AGENT; DOPAMINE 2 RECEPTOR STIMULATING AGENT; DOPAMINE RECEPTOR AFFECTING AGENT; HALOPERIDOL; MUSCIMOL; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; PICROTOXIN; QUINPIROLE; SULPIRIDE;

ABSENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BASAL GANGLION; BEHAVIOR; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC TRANSMISSION; ELECTROENCEPHALOGRAM; GENETIC MODEL; HISTOLOGY; MALE; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT; SEIZURE; SUBSTANTIA NIGRA;

ANIMALS; CORPUS STRIATUM; DOPAMINE; DOPAMINE AGONISTS; DOPAMINE ANTAGONISTS; EPILEPSY, ABSENCE; MALE; NUCLEUS ACCUMBENS; RATS; RATS, WISTAR; SUBSTANTIA NIGRA; SYNAPTIC TRANSMISSION;

EID: 0034648731     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(00)00266-9     Document Type: Article

References (64)

1. Afifi A. Basal ganglia: functional anatomy and physiology. Part 2. J. Child Neurol. 9:1994;352-361.
2. Akkal D., Burbaud P., Audin J., Bioulac B. Responses of substantia nigra pars reticulata neurons to intrastriatal D1 and D2 dopaminergic agonist injections in the rat. Neurosci. Lett. 213:1996;66-70.
3. Al-Tajir G., Starr M.S. Anticonvulsant effect of striatal dopamine D2 receptor stimulation: dependence on cortical circuits? Neuroscience. 43:1991;51-57.
4. Al-Tajir G., Starr M.S. D-2 agonists protect rodents against pilocarpine-induced convulsions by stimulating D-2 receptors in the striatum, but not in the substantia nigra. Pharmac. Biochem. Behav. 39:1991;109-113.
5. Alexander G., Crutcher M. Functional architecture of basal ganglia circuits neural substrates of parallel processing. Trends Neurosci. 13:1990;266-271.
6. Alexander G., DeLong M., Strick P. Parallel organization of functionnally segregated circuits linking basal ganglia and cortex. A. Rev. Neurosci. 9:1986;357-381.
7. Bordi F., Meller E. Enhanced behavioral stereotypies elicited by intrastriatal injection of D1 and D2 dopamine agonists in intact rats. Brain Res. 504:1989;276-283.
8. Cavalheiro E., Turski L. Intrastriatal N-methyl-D-aspartate prevents amygdala kindled seizures in rats. Brain Res. 377:1986;173-176.
9. Curran E.J., Watson S.J. Jr. Dopamine receptor mRNA expression patterns by opioid peptide cells in the nucleus accumbens of the rat: a double in situ hybridization study. J. comp. Neurol. 361:1995;57-76.
10. Danober L., Deransart C., Depaulis A., Vergnes M., Marescaux C. Pathophysiological mechanisms of genetic absence epilepsy in the rat. Prog. Neurobiol. 55:1998;27-57.
11. De Sarro G., Meldrum B., Reavill C. Anticonvulsant action of 2-amino-7-phosphonoheptanoic acid in the substantia nigra. Eur. J. Pharmac. 106:1985;175-179.
12. Deniau J.M., Menetrey A., Thierry A.M. Indirect nucleus accumbens input to the prefrontal cortex via the substantia nigra pars reticulata: a combined anatomical and electrophysiological study in the rat. Neuroscience. 61:1994;533-545.
13. Deniau J. M. and Thierry A. M. (1997) Anatomical segregation of information processing in the rat substantia nigra pars reticulata. In The Basal Ganglia and New Surgical Approaches for Parkinson's Disease, Advances in Neurology, Vol. 74 (eds Obeso J. A., DeLong M. R., Ohye C. and Marsden C. D.), pp. 83-96. Lippincott-Raven, Philadelphia.
14. Depaulis A., Vergnes M., Marescaux C. Endogenous control of epilepsy: the nigral inhibitory system. Prog. Neurobiol. 42:1994;33-52.
15. Depaulis A., Vergnes M., Liu Z., Kempf E., Marescaux C. Involvement of the nigral output pathways in the inhibitory control of the substantia nigra over generalized non-convulsive seizures in the rat. Neuroscience. 39:1990;339-349.
16. Deransart C., Marescaux C., Depaulis A. Involvement of nigral glutamatergic inputs in the control of seizures in a genetic model of absence epilepsy in the rat. Neuroscience. 71:1996;721-728.
17. Deransart C. (1998) Rôle des ganglions de la base dans le contrôle des crises épileptiques chez le rat. PhD dissertation, Université Louis Pasteur, Strasbourg.
18. Deransart C., Lê B.T., Marescaux C., Depaulis A. Role of the subthalamo-nigral input in the control of amygdala-kindled seizures in the rat. Brain Res. 807:1998;78-83.
19. Deransart C., Riban V., Lê B.T., Hechler V., Marescaux C., Depaulis A. Evidence for the involvement of the pallidum in the modulation of seizures in a genetic model of absence epilepsy in the rat. Neurosci. Lett. 265:1999;131-134.
20. Gale K. Mechanisms of seizure control mediated by gamma aminobutyric acid: role of the substantia nigra. Fedn Proc. 44:1985;2414-2424.
21. Gerfen C.R., Engber T.M., Mahan L.C., Susel Z., Chase T.N., Monsma F.J., Sibley D.R. D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons. Science. 250:1990;1429-1432.
22. Groenewegen H. and Berendse H. (1994) Anatomical relationships between the prefrontal cortex and the basal ganglia in the rat. In Motor and Cognitive Functions of the Prefrontal Cortex (ed. Thierry A. M.), pp. 51-77. Springer, Berlin.
23. Guey J., Bureau M., Dravet C., Roger J. A study of the rhythm of petit mal absences in children in relation to prevailing situations. The use of EEG telemetry during psychological examinations, school exercises and periods of inactivity. Epilepsia. 10:1969;441-451.
24. Heimer L., Zahm D. and Alheid G. (1995) Basal ganglia. In The Rat Nervous System (ed. Paxinos G.), pp. 579-628. Academic, San Diego.
25. Huff R.M. Signal transduction pathways modulated by the D-2 subfamily of dopamine receptors. Cell Signal. 8:1996;453-459.
26. Jensen A.A., Pedersen U.B., Din N., Andersen P.H. The dopamine D-1 receptor family: structural and functional aspects. Biochem. Soc. Trans. 24:1996;163-169.
27. Joel D., Weiner I. The organization of the basal ganglia-thalamocortical circuits: open interconnected rather than closed segregated. Neuroscience. 68:1994;363-379.
28. Jung R. Blocking of petit-mal attacks by sensory arousal and inhibition of attacks by an active change in attention during the epileptic aura. Epilepsia. 3:1962;435-437.
29. Koob G., Bloom F. Cellular and molecular mechanisms of drug dependence. Science. 242:1988;715-723.
30. Lannes B., Micheletti G., Vergnes M., Marescaux C., Depaulis A., Warter J. Relationship between spike-wave discharges and vigilance levels in rats with spontaneous petit mal-like epilepsy. Neurosci. Lett. 9:1988;187-191.
31. Le Moal M., Simon H. Mesocorticolimbic dopaminergic network: functional and regulatory roles. Physiol. Rev. 71:1991;155-234.
32. Le Moine C., Bloch B. D1 and D2 dopamine receptor gene expression in the rat striatum: sensitive cRNA probes demonstrate prominent segregation of D1 and D2 mRNAs in distinct neuronal populations of the dorsal and ventral striatum. J. comp. Neurol. 355:1995;418-426.
33. Lester J., Fink S., Aronin N., DiFiglia M. Colocalization of D1 and D2 dopamine receptor mRNAs in striatal neurons. Brain Res. 621:1993;106-110.
34. Levy R., Hazrati L.N., Herrero M.T., Vila M., Hassani O.K., Mouroux M., Ruberg M., Asensi H., Agid Y., Feger J., Obeso J.A., Parent A., Hirsch E.C. Re-evaluation of the functional anatomy of the basal ganglia in normal and parkinsonian states. Neuroscience. 76:1997;335-343.
35. Lu X.Y., Ghasemzadeh M.B., Kalivas P.W. Expression of D1 receptor, D2 receptor, substance P and enkephalin messenger RNAs in the neurons projecting from the nucleus accumbens. Neuroscience. 82:1998;767-780.
36. Maggio R., Gale K. Seizures evoked from area tempestas are subject to control by GABA and glutamate receptors in substantia nigra. Expl Neurol. 105:1989;184-188.
37. Maurice N., Deniau J., Menetrey A., Glowinski J., Thierry A. Position of the ventral pallidum in the rat prefrontal cortex-basal ganglia circuit. Neuroscience. 80:1997;523-534.
38. Maurice N., Deniau J.M., Glowinski J., Thierry A.M. Relationships between the prefrontal cortex and the basal ganglia in the rat: physiology of the cortico-nigral circuits. J. Neurosci. 19:1999;4674-4681.
39. McAlonan G., Robbins T., Everitt B. Effects of medial dorsal thalamic and ventral pallidal lesions on the acquisition of a conditioned place preference: further evidence for the involvement of the ventral striatopallidal system in reward-related processes. Neuroscience. 52:1993;606-620.
40. Meldrum B., Millan M., Patel S., De Sarro G. Anti-epileptic effects of focal micro-injection of excitatory amino acid antagonist. J. neural. Transm. 72:1988;191-200.
41. Mink J.W. The basal ganglia: focused selection and inhibition of competing motor programs. Prog. Neurobiol. 50:1996;381-425.
42. Missale C., Nash S.R., Robinson S.W., Jaber M., Caron M.G. Dopamine receptors: from structure to function. Physiol. Rev. 78:1998;189-225.
43. Morari M., Oconnor W.T., Ungerstedt U., Bianchi C., Fuxe K. Functional neuroanatomy of the nigrostriatal and striatonigral pathways as studied with dual probe microdialysis in the awake rat. 2. Evidence for striatal N-methyl-D-aspartate receptor regulation of striatonigral GABAergic transmission and motor function. Neuroscience. 72:1996;89-97.
44. Osonoe M., Mori N., Hoshino S., Yamada Y., Osonoe K., Kittaka H., Iwata Y. The effects of N-methyl-D-aspartate (NMDA) and its competitive antagonist, 3-(2-carboxypiperazine-4-yl)propyl-1-phosphonic acid (CPP), injected into caudate-putamen on kindled amygdaloid seizures in rats. Brain Res. 728:1996;242-246.
45. Ossowska K., Karcz M., Wardas J., Wolfarth S. Striatal and nucleus accumbens D1/D2 dopamine receptors in neuroleptic catalepsy. Eur. J. Pharmac. 182:1990;327-334.
46. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates. 1986;Academic, New York.
47. Pierce R.C., Kalivas P.W. Amphetamine produces sensitized increases in locomotion and extracellular dopamine preferentially in the nucleus accumbens shell of rats administered repeated cocaine. J. Pharmac. exp. Ther. 275:1995;1019-1029.
48. Redgrave P., Dean P., Simkins M. Intratectal glutamate suppresses pentylenetetrazole-induced spike-and wave discarges. Eur. J. Pharmac. 158:1988;283-287.
49. Robertson S., Jian M. D1 and D2 dopamine receptors differentially increase fos-like immunoreactivity in accumbal projections to the ventral pallidum and midbrain. Neuroscience. 64:1995;1019-1034.
50. A receptors in seizures of adult rats. Brain Res. 1989:1989;378-382.
51. Starr M.S. Glutamate/dopamine D-1/D-2 balance in the basal ganglia and its relevance to Parkinson's disease. Synapse. 19:1995;264-293.
52. Starr M.S. The role of dopamine in epilepsy. Synapse. 22:1996;159-194.
53. Surmeier D.J., Eberwine J., Wilson C.J., Cao Y., Stefani A., Kitai S.T. Dopamine receptor subtypes colocalize in rat striatonigral neurons. Proc. natn. Acad. Sci. USA. 89:1992;10,178-10,182.
54. Surmeier D.J., Reiner A., Levine M.S., Ariano M.A. Are neostriatal dopamine receptors co-localized? Trends Neurosci. 16:1993;299-305.
55. Swanson C.J., Heath S., Stratford T.R., Kelley A.E. Differential behavioral responses to dopaminergic stimulation of nucleus accumbens subregions in the rat. Pharmac. Biochem. Behav. 58:1997;933-945.
56. Turski L., Cavalheiro E.A., Turski W.A., Meldrum B. Excitatory neurotransmission within substantia nigra pars reticulata regulates threshold for seizures produced by pilocarpine in rats: effect of intranigral 2-amino-7-phosphonoheptanoate and N-methyl-D-aspartate. Neuroscience. 18:1986;61-77.
57. Turski L., Cavalheiro E.A., Bortolotto Z.A., Ikonomidou-Turski C., Kleinrok Z., Turski W.A. Dopamine-sensitive anticonvulsant site in the rat striatum. J. Neurosci. 8:1988;4027-4037.
58. Turski L., Meldrum B.S., Cavalheiro E.A., Calderazzo-Filho L.S., Bortolotto Z.A., Ikonomidou-Turski C., Turski W.A. Paradoxical anticonvulsant activity of the excitatory amino acid N-methyl-D-aspartate in the rat caudate-putamen. Proc. natn. Acad. Sci. USA. 84:1987;1689-1693.
59. Veliskova J., Velsek L., Moshe S.L. Subthalamic nucleus: a new anticonvulsant site in the brain. NeuroReport. 7:1996;1786-1788.
60. Vercueil L., Benazzouz A., Deransart C., Bressand K., Marescaux C., Depaulis A., Benabid A.L. High-frequency stimulation of the sub-thalamic nucleus suppresses absence-seizures in the rat: comparison with neurotoxic lesions. Epilepsy Res. 31:1998;39-46.
61. Vergnes M., Marescaux C., Boehrer A., Depaulis A. Are rats with genetic absence epilepsy behaviorally impaired? Epilepsy Res. 9:1991;97-104.
62. Wahnschaffe U., Löscher W. Anticonvulsant effects of ipsilateral but not controlateral microinjections of the dopamine D2 agonist LY 171555 into the nucleus accumbens of amygdala-kindled rats. Brain Res. 553:1991;181-187.
63. Warter J., Vergnes M., Depaulis A., Tranchant C., Rumbach L., Micheletti G., Marescaux C. Effect of drugs affecting dopaminergic neurotransmission in rats with spontaneous petit mal-like seizures. Neuropharmacology. 27:1988;269-274.
64. Yang C.R., Mogenson G.J. Ventral pallidal neurons responses to dopamine receptor stimulation in the nucleus accumbens. Brain Res. 489:1989;237-246.